Nov 01, 2023
257:250
For every 250 shares held, investors received 257. The price per share adjusted from $0.44 to $0.43.
The split itself did not change the total investment value.
Paradigm Biopharmaceuticals Limited (PBIGF) trades on the Other OTC in the Biotechnology industry.
Paradigm Biopharmaceuticals Limited company overviewThe latest split shown was on November 1, 2023. It was a 257-for-250 forward split, so shareholders received 257 shares for every 250 they held.
This history records one forward split, on November 1, 2023.
Already premium? Sign in